Related Experiment Videos
Laparoscopic total mesorectal excision for rectal cancer surgery
Jacques Marescaux1, Francesco Rubino, Joel Leroy
1IRCAD - European Institute of Telesurgery, University Louis Pasteur, Strasbourg, France. Jacques.Marescaux@ircad.u-strasbg.fr
Digestive Diseases (Basel, Switzerland)
|December 15, 2005
Summary
Laparoscopic total mesorectal excision shows promise for rectal cancer surgery. This review examines its feasibility, safety, and oncologic outcomes for operable rectal cancer patients.
Area of Science:
- Oncology
- Surgical Oncology
- Minimally Invasive Surgery
Background:
- Total mesorectal excision (TME) significantly improved outcomes for rectal cancer patients since the 1980s.
- Laparoscopic surgery is increasingly accepted for colon cancer due to proven oncologic safety.
- Rectal cancer has been largely excluded from trials comparing laparoscopic to open surgery due to technical challenges and disease characteristics.
Purpose of the Study:
- To review the feasibility, safety, and oncologic outcomes of laparoscopic TME for operable rectal cancer.
- To assess the current evidence for minimally invasive approaches in rectal cancer surgery.
Main Methods:
- Systematic review of published studies on laparoscopic TME for rectal cancer.
- Analysis of data regarding surgical technique, safety, and oncologic results.
Main Results:
- Laparoscopic TME is technically feasible and safe for selected rectal cancer patients.
- Early oncologic outcomes appear comparable to open TME, but long-term data is limited.
- Reported complication rates and hospital stays are often favorable compared to open surgery.
Conclusions:
- Laparoscopic TME is a viable option for rectal cancer treatment, offering potential benefits in recovery.
- Further high-quality research, including randomized trials, is needed to confirm long-term oncologic efficacy and establish standardized techniques.